Mei-Sheng Tai

Highly specific in vivo tumor targeting by monovalent and divalent forms of 741F8 anti-c-erbB-2 single-chain Fv.

Gregory P. Adams, John E. McCartney, Mei-Sheng Tai et al. · PubMed · 1993 · 252 citations

Anti-c-erbb-2 Single-chain Fv, Medicine, Immunology +14

[3] Protein engineering of single-chain Fv analogs and fusion proteins

James S. Huston, M Mudgett-Hunter, Mei-Sheng Tai et al. · Methods in enzymology on CD-ROM/Methods in enzymology · 1991 · 211 citations

Single-chain Fv Analogs, Engineering, Protein Assembly +7

Avidity-Mediated Enhancement of <i>In vivo</i> Tumor Targeting by Single-Chain Fv Dimers

Gregory P. Adams, Mei-Sheng Tai, John E. McCartney et al. · Clinical Cancer Research · 2006 · 100 citations · Full text

Mammalian Cell Expression of Single–Chain Fv (sFv) Antibody Proteins and Their C–terminal Fusions with Interleukin–2 and Other Effector Domains

Haimanti Dorai, John E. McCartney, Robert M. Hudziak et al. · Nature Biotechnology · 1994 · 61 citations

Immunology, Immune Regulation, Mammalian Cell Expression +10

Engineering disulfide-linked single-chain Fv dimers [(sFv')₂] with improved solution and targeting properties: anti-digoxin 26–10 (sFv')₂ and anti-c-erbB-2 741F8 (sFv')₂ made by protein folding and bonded through C-terminal cysteinyl peptides

John E. McCartney, Mei-Sheng Tai, Robert M. Hudziak et al. · Protein Engineering Design and Selection · 1995 · 44 citations